Board Member
TuHURA Biosciences, Inc. (HURA)Equibles does not estimate personal net worth.
Get an email with a short summary when TuHURA Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get HURA alertsJames Bianco is recorded as Board Member and CEO at TuHURA Biosciences, Inc. (HURA). The newest filing on record that lists James Bianco as Board Member and CEO at TuHURA Biosciences, Inc. (HURA) is dated July 9, 2026. TuHURA Biosciences, Inc. reported in an 8-K filed October 21, 2024 that James Bianco was appointed Chief Executive Officer, effective October 18, 2024. TuHURA Biosciences, Inc. reported in an 8-K filed October 21, 2024 that James Bianco was appointed director, effective October 18, 2024. James Bianco has spoken on 1 investor event across 1 company, most recently for TuHURA Biosciences, Inc. on August 12, 2026. TuHURA Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at TuHURA Biosciences, Inc. includes Dr. James Bianco (CEO), James Bianco, M.D. (CEO), James Manuso (Chairman and Board Member) and 7 others.
“On October 18, 2024, the Company's board of directors appointed James Bianco, M.D. as the Chief Executive Officer, Daniel Dearborn as the Chief Financial Officer and Dennis Yamashita, Ph.D as the Chief Scientific Officer.”
“Effective upon the closing of the Merger on October 18, 2024, the size of the board of directors was increased to five members and the board of directors of the Company was reconstituted as follows: (i) Robert E. Hoffman (designated by Kintara), and (ii) James Manuso, M.D., James Bianco, Alan List and George Ng (designated by TuHURA).”
“Before we get started, as typical with presentations of this variety, we will be making forward-looking statements and we refer you to our SEC filings for more information on the company.”
Start not stated–present
Last confirmed July 9, 2026
Start not stated–present
Last confirmed July 9, 2026
Biotechnology · Healthcare
Board Member, CEO
